Intellectual Property News & Topics - Secerna LLP

REXULTI

A to Z: Drugs in Highlight: R is for REXULTI®

News A to Z Feature 03/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.

Read more

Newcastle Tyne Bridge [Unsplash]

News, Team news 16/04/2023

Secerna Expands to Newcastle with New City Centre Office

Alarm Clocks April 2023

Industry news, News 11/04/2023

New EPO Guidance on Notification Changes that will Abolish the Ten-Day Rule

Shutterstock 1556606726

Industry news, News 04/04/2023

Intellectual Property Status Quo Preserved as the UK Joins Comprehensive and Progressive Trans-Pacific Partnership

B012753

Events, News 17/03/2023

Secerna to attend BioMedica conference

Conference

Industry news 08/03/2023

Secerna to attend Made Smarter Advanced Manufacturing Technology Showcase in Sunderland

GB1 7522 Holly Image 1

Team news, Careers 07/03/2023

Holly Smith in profile

Wf Alt

Industry news, News 07/03/2023

UK court decision relating to renewable energy technology defines the territorial field of patent law

Tick List

Industry news, News 01/03/2023

Navigating the European Regional Phase (ERP) of your patent application

Istock 841265342

Industry news, News 10/02/2023

EPO Added Matter “Not a Commacal Matter”

15 16 17 18 19 20 21 22 23 24 25